AMANDA WOOD: Open Payments
NPI 1801440102 · COEUR D ALENE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,717 in 89 payments from 26 companies in 2025. Trend: 2023 $275 · 2024 $484 · 2025 $1,717
Food & beverage: $1,717
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 16 | $236 |
| ABBVIE INC. | 6 | $168 |
| PFIZER INC. | 7 | $160 |
| Merck Sharp & Dohme LLC | 8 | $153 |
| E.R. Squibb & Sons, L.L.C. | 8 | $142 |
| Janssen Biotech, Inc. | 6 | $118 |
| Lilly USA, LLC | 5 | $90 |
| Eisai Inc. | 4 | $86 |
| GlaxoSmithKline, LLC. | 4 | $77 |
| GENZYME CORPORATION | 3 | $58 |
Products named: KEYTRUDA, KISQALI, OPDIVO, SCEMBLIX, EPKINLY, Lenvima, ELREXFIO, OJJAARA.
Industry payments across ID — which companies pay providers there.
